Costly mistakes can happen when rushing through process development to produce curative therapies for genetic diseases. Learn about 3 key strategies that can be leveraged to improve product yield, quality, and patient safety.
Not yet a member of Cell & Gene? Register today.
Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.
You might also want to: